Early attempts at adoptive T cell therapy focused on introducing T cells specific for tumor associated antigens including MAGE-A3 in melanoma and carcinoembryonic antigen (CEA) in colorectal cancer (10, 11). This evidence concerns the gene CEACAM5 and colorectal cancer.